MEI Pharma (MEIP)
(Delayed Data from NSDQ)
$3.05 USD
-0.05 (-1.61%)
Updated Apr 26, 2024 03:44 PM ET
After-Market: $3.08 +0.03 (0.98%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -1.38 |
EPS Last Quarter | -1.66 |
Last EPS Surprise | -13.70% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 3.24 |
Next Year | -4.98 |
EPS (TTM) | 2.97 |
P/E (F1) | 0.96 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.08M | 0.10M | 65.47M | 12.50M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.08M | 0.10M | 65.47M | 12.50M |
Low Estimate | 0.08M | 0.10M | 65.47M | 12.50M |
Year ago Sales | 5.89M | 1.46M | 48.82M | 65.47M |
Year over Year Growth Est. | -98.64% | -93.15% | 34.12% | -80.91% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.38 | -1.51 | 3.24 | -4.98 |
# of Estimates | 2 | 2 | 1 | 1 |
Most Recent Consensus | -1.42 | -1.56 | NA | NA |
High Estimate | -1.34 | -1.46 | 3.24 | -4.98 |
Low Estimate | -1.42 | -1.56 | 3.24 | -4.98 |
Year ago EPS | -2.32 | -1.51 | -5.02 | 3.24 |
Year over Year Growth Est. | 40.52% | 0.00% | 164.54% | -253.70% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | -1.38 | -1.51 | 3.24 | -4.98 |
7 Days Ago | -1.38 | -1.51 | 3.24 | -4.98 |
30 Days Ago | -1.38 | -1.51 | 3.24 | -4.98 |
60 Days Ago | -1.38 | -1.51 | 3.24 | -4.98 |
90 Days Ago | -1.36 | -1.50 | 3.48 | -4.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.38 | -1.51 | 3.24 | -4.98 |
Zacks Consensus Estimate | -1.38 | -1.51 | 3.24 | -4.98 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.66 | 8.46 | -1.51 | -2.32 | NA |
Estimate | -1.46 | -1.47 | -3.25 | -2.60 | NA |
Difference | -0.20 | 9.93 | 1.74 | 0.28 | 2.94 |
Surprise | -13.70% | 675.51% | 53.54% | 10.77% | 181.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more